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Abstract: 
Xylocarpus granatum (Family: Meliaceae) is a mangrove tree species used as herbal remedy for various ailments. 
But the scientific basis for its medicinal use especially in pain andinflammation remains unknown. Therefore, the 
present study was aimed toinvestigate the anti-nociceptive and anti-inflammatory effects of the leaves of Xylocarpus 
granatum in laboratory animals. The anti-nociceptive effect was assessed in mice using acetic acid-induced 
writhing, formalin-induced paw licking and tail immersion assays. Anti-inflammatory activity was evaluated on 
carrageenan induced paw oedema in rats. In acetic acid-induced writhing test, the extract at different doses (50 and 
100 mg/kg) significantly (p <0.001) and dose-dependently reduced pain by 49.30 and 68.20%, respectively. The 
extract also significantly inhibited both the early and late phases of formalin-induced paw licking in mice. In the tail 
immersion test, the extract caused a significant inhibition of pain (68.91% inhibition, after 4 hr.) at a dose of 100 
mg/kg. X. granatum caused a significant inhibition of paw oedema development in the carrageenan-induced oedema 
tests. The findings of the study suggested that X. granatum leaves have significant anti-nociceptive and anti-
inflammatory effects, confirming the traditional use of this plant in the treatment of various diseases associated with 
pain and inflammation. 
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INTRODUCTION: 
Inflammation is a complex physiological and 
pathological process accompanied by the activation 
of the immune system, local vascular system, and 
various cells within the damaged tissue [1]. It is a 
normal protective response to tissue injury caused by 
physical trauma (cut, burn or bruise), noxious 
chemicals, microbiologic agents or even autoimmune 
disease. Acute inflammation is a part of the defense 
response by organisms to remove injurious stimuli, 
such as pathogens, irritants, or physical injury, from 
tissues and to initiate the healing process. However, 
epidemiological studies have demonstrated that 
chronic inflammation is associated with a wide 
variety of diseases, including cardiovascular diseases, 
cancers, diabetes, arthritis, Alzheimer’s disease, 
pulmonary diseases, and autoimmune diseases [2]. 
Although several drugs are currently available for the 
treatment of chronic inflammation, they also produce 
various side effects and have relatively low efficacy. 
Therefore, identification of new molecules with high 
efficacy and low side effects for the treatment of 
chronic inflammation related diseases is currently of 
great interest. 
 
Xylocarpus granatum is a mangrove tree species 
belonging to the family Meliaceae. It is well 
distributed in the coastal areas of Australia, South 
East Asia including Malaysia and Bangladesh, and 
India [3]. X. granatum is a medicinally important 
mangrove plant the bark of which has been used in 
traditional medicine for the treatment of fevers, 
malaria, and cholera [4]. Apart from these traditional 
uses, scientific studies on X. granatum have shown it 
to possess various biological activities that include 
antifilarial, antifungal, and anticancer activities [4,5]. 
The leaves and barks of X. granatum have been 
found to possess significant radical scavenging 
activity [6,7]. Ethanol extracts of whole fruits of this 
plant have also exhibited antihyperglycemic and 
antidyslipidemic activities in streptozotocin (STZ)-
induced rats [8]. However, no study has been 
conducted to evaluate anti-nociceptive and anti-
inflammation activity of the leaf extracts from this 
plant. Therefore, the present study has been carried 
out to explorethe anti-nociceptive and anti-
inflammatory activities of ethanolic extracts of X. 
granatum on animal models. 
 
MATERIALS AND METHODS: 
Plant Material 
The plant sample of X. granatum leaves were 
collected in September, 2016 from coastal area of 
Bangladesh. The plant was identified by Bangladesh 
National Herbarium, Dhaka, where a voucher 
specimenhas been deposited. At first, Leaves were 
washed properly to remove dirty materials and air-
dried for several days. These were then ground with a 
hammer grinder for better grinding. The dried leaves 
were ground into a coarse powder. Then, the dried 
powder was preserved in an airtight container. 
 
Extract preparation: 
The collected plant leaves were washed with water 
and separated from undesirable materials or plants or 
plant parts. They were aerated by fan aeration to be 
partially dried and were next heated in an oven at 
below 40ºC for two days to be fully dried. The fully 
dried leaves are then grinded to make them powder 
by the help of a suitable grinder. Then the powders 
were dissolved in ethanol and kept for a period of 2 
days accompanying occasional shaking and stirring. 
The whole mixture then underwent a coarse filtration 
by a piece of clean, white cotton material followed by 
a second filtration through whatman filter paper. The 
filtrate (ethanol extract) obtained was evaporated by 
rotary evaporatorat 5 to 6 rpm and at 68ºC 
temperature. It rendered a gummy concentrate that 
was designated as crude extract or ethanolic extract. 
The crude ethanolic extract was finally dried by 
freeze drier and preserved. 
Experimental Animals: 
Swiss Albino mice (25-30 gm) and Wistar male rat 
(150-200 gm) obtained from the Animal Resource 
Branch of the International Centre for Diarrhoeal 
Diseases and Research, Bangladesh (ICDDR, B) 
were used for the experiment. They were kept in 
standard environmental condition for one week in the 
animal house of the Department of Pharmacy, 
Daffodil International University, Bangladesh for 
adaptation after their purchase. The animals were 
provided with standard laboratory food and tap water 
ad libitum and maintained at natural day night cycle. 
This study was approved by the Internal Ethics 
committee for the use and care of laboratory animals, 
Daffodil InternationalUniversity, Bangladesh. 
 
Drugs and chemicals: 
Diclofenac Na (MERCK, Mumbai, India), 
Indomethacin (BASF Aktiengesellschaft, Germany), 
Formaldehyde (MERCK, Mumbai, India), 
Carrageenan (Hi Media Laboratories Pvt. Ltd., 
Mumbai, India) and 0.9% NaCl saline solution 
(Square Pharmaceuticals Ltd., Bangladesh) were 
used. All other reagents were of analytical grade. 
 
Acute oral toxicity test 
An acute oral toxicity test was carried out in 
accordance with the Organisation for Economic 
Cooperation and Development (OECD) guidelines 
for testing of chemicals [9]. Swiss albino mice 
IAJPS 2019, 06 (05), 9596-9602                    Howlader Sauravet al                   ISSN 2349-7750 
 
 w w w . i a j p s . c o m  
 
Page 9598 
maintained under standard laboratory conditions 
being used for the acute toxicity study. A total of 
three mice from each group received a single oral 
dose (500, 1000, and 2000 mg/kg bw) of the extract. 
Animals were fasted overnight prior to 
administration. After administration of the extracts, 
food was withheld for a further 3 to 4 h. The animals 
were then individually observed (with special 
attention during the first 4 h) for possible behavioural 
changes, allergic reactions (skin rash, itching), eyes 
and mucous membrane, and mortality for the next 72 
h. 
 
Anti-nociceptive activity 
Acetic acid-induced writhing test 
For the writhing test, the animals were divided into 
four groups including control (Group I), positive 
control (Group II) and two test groups (Group III-
IV). The control group was treated with 1% tween 80 
in saline water at the dose of 10 ml/kg p.o. and the 
positive control group received indomethacin 
(standard drug) at the dose of 10 mg/kg orally. The 
animals of groups III and group IV were treated with 
plant extracts at two different doses of 50 mg/kg and 
100 mg/kg bw orally. Thirty minutes after 
administration of vehicle, standard drug and test 
samples, 0.7% acetic acid is injected intraperitoneally 
(i.p.) at a dose of 10 ml/kg bw and the intensity of 
analgesic behaviour was quantified by counting the 
total number of writhes over a period of 30 minutes. 
The percentage analgesic activity was calculated as 
follows: 
 
Percentage analgesic activity = [(Nc - Nt)/Nc] × 
100%, Where Nc is the average number of writhes of 
the control group and Nt is the average number of 
writhes of the test/positive control group.  
 
Formalin-induced paw licking test 
The formalin-induced paw licking method was 
performed according to Gharate and kasture, 2013 
[10]. For this method, animals were kept in four 
groups,with 4 mice in each, and were treated in the 
following manner: group I received vehicle (isotonic 
saline solution, 0.9%), group II received 
indomethacin as standard drug at the dose of 10 
mg/kg bw and group III-IV received ethanolic extract 
of X. granatum (50 and 100 mg/kg of bw). One hour 
after the oral administration of vehicle, standard drug 
and test samples, mice received 20 µl of 2% formalin 
in sub plantar region of hind paw and the number of 
paw licking events was measured in each mouse from 
0-5 min and 20-30 min. The number of paw licks in 
the first 5 min indicates response to neurogenic pain 
and the number of paw licks in 20-30 min indicates 
inflammatory pain.  
Tail immersion method 
The tail immersion test was performed to evaluate 
analgesic activity by Mali et al., [11]. In this test, 
mice were divided into four groups of 4 mice, each 
treated orally with vehicle (isotonic saline solution, 
0.9%), diclofenac sodium as standard drug (10 
mg/kg) and ethanolic extract of X. granatum (50 and 
100 mg/kg of bw). One hour after administration of 
the vehicle, standard drug and test samples, the tip of 
the tail was immersed up to 5 cm in hot water 
maintained at 55°C. Sudden withdrawal of the tail 
from the hot water was taken as the reaction time. To 
avoid damage to the tail, a cut-off time of 20 s was 
maintained. The reaction time was measured at 0, 1, 
2, 3, 4 and 5 h.  
 
Anti-inflammatory Activity 
Carrageenan-induced rat paw oedema test 
The method described by Mali et al., [11] was used to 
study acute inflammation. In this experiment, rats 
were divided into four groups of four mice and were 
treated orally with vehicle 1 ml/kg (Group I), 
diclofenac sodium 10 mg/kg (Group II) and ethanolic 
extract of X. granatum (50 and 100 mg/kg of bw for 
Groups III and IV, respectively). One hour after 
administration of the vehicle, standard drug and plant 
extract, 0.1 ml of 1% w/v of carrageenan suspension 
in 0.9% normal saline was injected into the sub 
planter region of the left hind paw of the rat. The paw 
volume was determined with a micrometre screw 
gause at 1, 2, 3, 4 and 5 h after administration of the 
drug and the extract. The percentage inhibition in 
paw volume after administration of the extract was 
calculated using the following formula: Percentage 
inhibition in rat paw volume= (1-Vt/Vc) ×100, 
Where, Vt is the mean paw volume in control group 
and Vc is the mean paw volume in test group. 
Statistical analysis 
Statistical analysis was carried out using one-way 
ANOVA followed by Dunnet’s multiple comparisons 
for analgesic and anti-inflammatory tests. The results 
obtained were compared with the vehicle control 
group. P values <0.05, <0.01, <0.001 were 
considered to be statistically significant. 
 
RESULTS: 
Acute oral toxicity test 
In the acute toxicity assay, no deaths were observed 
duringthe 72 hr. period at the doses tested. At these 
doses, the animalsshowed no stereotypical symptoms 
associated withToxicity, such as convulsion, ataxia, 
diarrhoea or increased diuresis. 
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Anti-nociceptive activity 
Acetic acid-induced writhing test 
The results of the ethanolic extract of X. granatum 
leaves on acetic acid-induced writhing in mice and 
percentage inhibition of pain are shown in Table 1. 
The percentage inhibition of writhing produced by 
the extracts at the dose of 100 mg/kg bw was 
68.20%; that result was statistically significant (P < 
0.001) compared to the standard drug indomethacin, 
which showed 75.67% writhing inhibition. 
 
Table 1. Effects of ethanolic extracts of X. granatum leaves on acetic acid-induced writhing tests 
Group No of Writhing % of Inhibition 
Control 30.37 ± 3.29 ………. 
Standard 10.26 ± 2.02*** 75.67% 
X. granatum (50 mg/kg) 28.15 ± 4.10* 49.3% 
X. granatum (100 mg/kg) 16.12 ± 2.23*** 68.20% 
Values are expressed as mean ± S.E.M. (n=5); significance at ***p<0.001, **p<0.01, *p<0.05 as compared to control 
 
Formalin-induced paw licking test 
The effects of the ethanol extract of X. granatum 
leaves on formalin induced paw licking in mice and 
percent of inhibition in both phage are shown in 
Table 2.  In the first phase of the formalin-induced 
pain model, ethanol extract at 100 and 50 mg/kg bw 
produced 42.14% and 25.84% inhibition of pain 
response whilst at the second phase,X. granatum leaf 
extract produced 49.25% and 20.17% inhibition of 
pain response, respectively. We found that X. 
granatum extract showed an analgesic effect both in 
the early and late phase of the formalin test which 
indicates that the extract exerts its analgesic effect 
through the peripheral and central mechanism. 
 
Table 2. Effects of ethanolic extracts of X. granatum leaves on formalin-induced test 
 
Group 
Early Phase 
0-5 min. 
% of inhibition  
in early phase 
Late Phase 
20-30 min. 
% of inhibition  
in late phase 
Control 34.00 ± 1.05 ……… 13.50 ± 2.10 ………… 
Standard 17.60 ± 1.50 50.15% 2.86 ± 1.30 82.01% 
X. granatum (50 mg/kg) 22.50 ± 10.02 25.84% 10.15 ± 5.10 20.17% 
X. granatum (100 mg/kg) 20.15 ± 12.39 42.14% 8.12 ± 3.04 49.25% 
Values are expressed as mean ± S.E.M. (n=5); significance at ***p<0.001, **p<0.01, *p<0.05 as compared to control 
 
Tail immersion test 
The effects of the ethanol extract of X. granatum 
leaves on Tail immersion test in mice were 
significant at the level of P<0.001; these are shown in 
Table 3. In the tail immersion method of analgesic 
activity, the ethanolic extract of X. granatum 
exhibited potent activity at 100 and 50 mg/kg bw the 
response time observed was significantly increased 
when compared to normal control. However, the 
standard Diclofenac sodium was found to have better 
activity than the extract during the 4hr response. 
Diclofenac sodium showed 80.15% inhibition 
whereas X. granatum showed 68.91% inhibition at 
tested concentration. 
 Table 3. Effects of ethanolic extracts of X. granatum leaves on tail-immersion method test 
 
Treatment 
Retention time in (sec) 
Initial Time after drug administration % of Inhibition 
0 hr 1 hr 2 hr 3 hr 4 hr 5 hr At 4 hr 
Control 12.65 ± 1.5 11 ± 1.16 10.25 ± 0.75 10.55 ± 1.2 14.15 ± 0.78 10.05 ± 0.54 ……. 
Standard 11.00 ± 0.16* 4.5 ± 1.2** 3.65 ± 1.8* 6.75 ± 1.1** 4 ± 1.15*** 5 ± 1.25* 80.15% 
X. granatum(50 
mg/kg) 12.75 ± 0.6 10.65 ± 0.78** 6.25 ± 0.45 9 ± 0.12 7.75 ± 0.28*** 5.56 ± 0.18* 54.63% 
X. 
granatum(100 
mg/kg) 15.25 ± 1.1 9.25 ± 0.52* 8.15 ± 1.5* 7.15 ± 0.46** 5 ± 0.81*** 6.05 ± 0.28* 68.91% 
Values are expressed as mean ± S.E.M. (n=5); significance at ***p<0.001, **p<0.01, *p<0.05 as compared to 
control 
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Anti-inflammatory activity 
Carrageenan-induced rat paw oedema test 
The anti-inflammatory effect of ethanolic extracts of 
X. granatum leaves was observed at the level of 
P<0.001 when compared with the vehicle distilled 
water (control group) and Diclofenac sodium 
(Standard). The percent inhibition of indomethacin in 
paw oedema after 4 hrs was recorded as 68.75%. 
Moreover, 100 mg/kg dose of ethanolic extracts of X. 
granatum leaves exhibited significance percent of 
inhibition which was recorded as 58.29%. The 
observations and significance at the level of P<0.001 
are shown in Table 4. 
 
Table 4. Effects of ethanolic extracts of X. granatumleaves on carrageenan-induced rat paw oedema test 
 
 
Treatment 
Retention time in (sec) 
Initial Time after drug administration % of Inhibition 
0 hr 1 hr 2 hr 3 hr 4 hr At 4 hr 
 
Control  2.04 ± 0.02 2.15 ± 0.01 2.50 ± 0.02 2.65 ± 0.01* 1.89 ± 0.01 ……. 
Standard 0.72 ± 0.012* 0.65 ± 0.007* 0.70 ± 0.022 0.55 ± 0.02** 0.42 ± 0.02*** 68.75% 
X. 
granatum(5
0 mg/kg)   0.88 ± 0.007 0.91 ± 0.002** 0.76 ± 0.014* 0.90 ± 0.016* 0.75 ± 0.015* 48.34% 
X. 
granatum(1
00 mg/kg)   0.53 ± 0.02 0.62 ± 0.03** 0.75 ± 0.016** 0.50 ± 0.009** 0.71 ± 0.017*** 58.29% 
Values are expressed as mean ± S.E.M. (n=5); significance at ***p<0.001, **p<0.01, *p<0.05 as compared to 
control 
DISCUSSION: 
Pain and inflammation are associated with 
pathophysiology of various diseases like arthritis, 
cancer and vascular diseases. Non-steroidal anti-
inflammatory drugs (NSAIDs) are commonly used 
for treatment of pain and inflammation. However, 
prolonged use of these drugs leads to gastro-intestinal 
ulcers, bleeding, and renal disorders [12]. Thus, there 
is a need for discovery of new anti-inflammatory and 
analgesic drugs without these side effects. A number 
of natural products are used in various traditional 
medicinal systems to relief symptoms of pain and 
inflammation [13]. Xylocarpus granatum is reported 
to contain chemical constituents which may exert 
analgesic and anti-inflammatory effect; however till 
now there has been no investigation supporting the 
anti-nociceptive and anti-inflammatory properties of 
this plant. 
 
Results of the present study showed that the ethanolic 
extract of X. granatum has marked anti-nociceptive 
and anti-inflammatory effects with a reasonable 
safety profile. The anti-nociceptive and anti-
inflammatory effect of ethanol leaves extract of X. 
granatum was evaluated for the first time in various 
experimental test models.Satyanarayana et al., [14] 
showed that acetic acid induces writhing by 
stimulating the production of prostaglandins. 
Standard analgesic drug Indomethacin has been 
shown to inhibit prostaglandin synthesis in the brain 
[15,16]. Since X. granatum therapy antagonised 
acetic acid-induced writhes, it is possible to suggest 
that the plant extract may be producing anti-
nociceptive activity through manipulation of the 
prostaglandin system. On the other hand, the 
formalin-induced paw licking model comprises of 
early phase and late phase. The early phase 
(immediately after injection) seems to be caused by 
C-fibre activation due to the peripheral stimulus. The 
late phase (20 min after formalin injection) appears to 
depend on the combination of an inflammatory 
reaction, activation of NMDA and non-NMDA 
receptors and NO cascade [17] in the peripheral 
tissue and the functional changes in the dorsal horn of 
the spinal cord. In our study, the ethanolic extract of 
X. granatum significantly inhibited the late phase of 
formalin-induced pain.The tail immersion test is used 
to determine both centrally acting analgesics [9], like 
Diclofenac Na [18],and peripherally acting analgesics 
like NSAIDs, which inhibit cyclooxygenase in 
peripheral tissues, thereby interfering with the 
mechanism of transduction of primary afferent 
nociceptors [19]. The results observed for the tail 
immersion test clearly showed that the ethanolic 
extract of X. granatum possessed a dose dependent 
anti-nociceptive activity.Carrageenan-induced edema 
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involves the synthesis or release of mediators at the 
injured site correlated with early exudative stage of 
inflammation [20]. These mediators include 
prostaglandins, especially the E series, histamine, 
bradykinins, leucotrienes and serotonin all of which 
also cause pain and fever [21]. The time course of 
edema development in carrageenan induced paw 
edema model in rats is generally represented by a 
biphasic curve. The first phase occurs within an hour 
of carrageenan injection and is partly due to the 
trauma of injection and also to histamine and 
serotonin component. The second phase (over 1h) is 
mediated by prostaglandins, the cyclooxygenase 
products, and the continuity between the two phases 
is provided by kinins [22]. The presence of PGE2 in 
the inflammatory exudates from the injected foot can 
be demonstrated at third hour and period thereafter. 
Inhibition of these mediators from reaching the 
injured site or from bringing out their 
pharmacological effects normally ameliorates the 
inflammation and other symptoms. Since 
carrageenan-induced inflammation model is a 
significant predictive test for anti-inflammatory 
agents acting by the mediators of acute inflammation 
[23], theresult of our current study is an indication 
that X. granatum can be effective in acute 
inflammatory disorders. Since the ethanol extract 
exhibited significant inhibition of edema volume at 
fourth hour after administration of carrageenan in 
comparison to control, the possible mechanism of 
anti-inflammatory activity of the extract may be its 
ability to inhibit the biosynthesis and/or release of 
prostaglandin-like substances. However the 
inhibitory effect on the release of histamine or 
serotonin like substances cannot be ruled out, 
because the extract showed significant inhibition of 
rat paw edema during first hour of carrageenan 
administration as well. Thus the extract may possess 
chemical constituents that may cause inhibition of the 
enzyme ‘cyclooxygenase’. 
 
The ethanolic leaf extract of X. granatum 
considerably reduced carrageenan-induced paw 
oedema in mice. Diclofenac also antagonised 
carrageenan-induced paw oedema in mice. 
Carrageenan-induced inflammatory pain is well 
known to involve inflammatory mediators like 
cyclooxygenase products (PGE2), leukotrienes 
histamine, 5-HT, and cytokines [24], which are 
released as a result of tissue injury. X. granatum 
reduced carrageenan-induced rat paw oedema, 
suggesting that the plant may have affected 
inflammatory mediators to produce its anti-
inflammatory activity.  
 
CONCLUSION: 
This study revealed the antinociceptive and anti-
inflammatory activity of ethanol extract of 
Xylocarpus granatum in a dose-dependent manner. 
Further investigations are required to isolate the 
active component of the extract and to confirm the 
mechanism of action in the development of a potent 
antinociceptive and anti-inflammatory compound. 
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